Traditional MedicareCoverageHigh impact
Anti-Cancer Chemotherapy for Colorectal Cancer - RETIRED
Medicare/CMS - NCD·Oncology, Hematology, Gastroenterology·National Coverage Determination
Effective date
Apr 23, 2026
We identified it
Jun 17, 2026
Summary
Medicare's National Coverage Determination 110.17 for Anti-Cancer Chemotherapy for Colorectal Cancer has been RETIRED as of April 23, 2026. This means the specific Medicare coverage guidelines for colorectal cancer chemotherapy under this NCD are no longer in effect, potentially affecting how these treatments are covered and billed.
Action Required
Immediately: Billing team must verify current coverage policies for colorectal cancer chemotherapy claims since NCD 110.17 is retired. Contact Medicare Administrative Contractor (MAC) to confirm new coverage guidelines and prior authorization requirements. Review all pending and future colorectal cancer chemotherapy claims to ensure compliance with updated coverage criteria. Update billing procedures and staff training materials to reflect new coverage determination processes.